In This Issue: Improving Opioid Safety
Primary Care Intervention to Reduce Prescription Opioid Overdoses
Previous studies by this research team indicate:
While efforts are underway to address prescriber behavior related to opioids (i.e., VA’s Opioid Safety Initiative), concurrent strategies that address patient behaviors are needed.
Investigators in this ongoing (2015–2019) HSR&D-funded randomized controlled trial (RCT) will evaluate a brief, tailored motivational enhancement intervention to reduce overdose risk behavior and aberrant opioid use among Veterans seen in VA primary care and Primary Care-Mental Health Integration (PC-MHI) settings. While motivational enhancement has demonstrated efficacy in numerous RCTs across a range of behaviors, to date, motivational enhancement has not been applied to overdose risk behaviors or aberrant opioid use in any VA setting. This intervention will:
Motivational enhancement therapy (MET) is designed to evoke internally motivated change by helping people with addictions learn how to change their thoughts and behaviors. MET includes five specific strategies that have been found to encourage motivational change:
The objectives of this RCT are to examine if patients randomly assigned to a motivational enhancement brief intervention for overdose prevention report reduced overdose risk behavior over one year of follow-up compared to an enhanced usual care condition (EUC). Investigators also will assess whether or not Veterans randomly assigned to a motivational enhancement brief intervention report reduced prescription opioid use over one year of follow-up compared to a usual care condition.
Principal Investigator: Amy Bohnert, PhD, MHS, is part of HSR&D’s Center for Clinical Management Research (CCMR) in Ann Arbor, MI, and is a former HSR&D’s Career Development Awardee.